Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MHRA’s Rawlins Plans British Version Of FDA’s Reg Science Centers

Executive Summary

The head of UK agency wants Britain to get its own version of the FDA’s Centers of Excellence in Regulatory Science and Innovation network to promote collaborations between it and academia to advance regulatory science through research, education, and scientific exchanges.

Advertisement

Related Content

Few UK "Promising Innovative Medicine" Holders Seek Joint MHRA/NICE Advice – Rawlins
Few UK "Promising Innovative Medicine" Holders Seek Joint MHRA/NICE Advice – Rawlins
FDA’s Hamburg Says EMA Could Be Model For Global Regulatory Coalition
MHRA’s Beneficial EU Relationship And Profitable Synergies With NICE: An Interview With Michael Rawlins
Good Neighbors Make Good Regulatory Science Centers, FDA Decides

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS057079

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel